Journal rankings · indicator year 2019
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2019
Hematology journal rankings 2019
80 ranked journals · Subfield in Medicine
Hematology has 80 ranked journals in 2019. The median OJR fell 0.06 on 2018 to 0.68, below the world average of 1.00; Q1 starts at OJR 1.27. The top three are Blood, The Lancet Haematology, and Leukemia.
Ranks and citation indicators: 2019. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2016–2018, the window the 2019 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
- Hematology80
Show all 42 subfields
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
80 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2018. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2016–2018, the window the 2019 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2016–2018 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2010 to 2019. | Compare |
|---|---|---|---|---|---|---|---|
1BloodElsevier BV · United States | 3.57Q1 | 9.63 0.12 down from 2018 | 2,647 | 9% | $5,500 | ||
2The Lancet HaematologyElsevier BV · Netherlands | 2.51Q1 | 5.71 0.57 down from 2018 | 314 | 47% | $7,280 | ||
3LeukemiaSpringer Nature · United Kingdom | 2.48Q1 | 7.55 1.01 up from 2018 | 1,031 | 62% | $5,190 | ||
4Blood ReviewsElsevier BV · United Kingdom | 2.40Q1 | 6.31 0.04 down from 2018 | 138 | 42% | $5,220 | ||
5Blood AdvancesOAElsevier BV · United States | 2.08Q1 | 5.60 1.39 up from 2018 | 688 | 100% | $3,800 | ||
6Blood Cancer JournalOASpringer Nature · United Kingdom | 1.97Q1 | 5.37 1.25 up from 2018 | 390 | 100% | $5,290 | ||
7HaematologicaOAFerrata Storti Foundation · Italy | 1.73Q1 | 4.40 0.21 down from 2018 | 1,198 | 100% | $2,157 | ||
8Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 1.72Q1 | 4.27 0.09 up from 2018 | 851 | 96% | $3,750 | ||
9Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.71Q1 | 4.71 0.95 up from 2018 | 78 | 100% | $2,650 | ||
10HematologyAmerican Society of Hematology · United States | 1.70Q1 | 4.14 0.51 up from 2018 | 273 | 95% | — | ||
11Pediatric RheumatologyOABioMed Central · United Kingdom | 1.70Q1 | 3.57 0.04 up from 2018 | 237 | 100% | $3,090 | ||
12Transfusion Medicine ReviewsElsevier BV · United States | 1.61Q1 | 4.39 0.14 down from 2018 | 92 | 33% | $3,970 | ||
13Seminars in HematologyElsevier BV · United States | 1.57Q1 | 3.67 0.70 down from 2018 | 142 | 10% | $4,070 | ||
14American Journal of HematologyWiley · United States | 1.51Q1 | 4.00 0.33 up from 2018 | 995 | 85% | $5,450 | ||
15Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.43Q1 | 3.72 0.01 up from 2018 | 214 | 34% | — | ||
16British Journal of HaematologyWiley · United Kingdom | 1.36Q1 | 3.35 0.24 down from 2018 | 1,500 | 58% | $5,190 | ||
17Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.30Q1 | 3.30 0.41 up from 2018 | 192 | 21% | $3,790 | ||
18Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.29Q1 | 3.78 0.44 up from 2018 | 1,077 | 100% | $3,650 | ||
19Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 1.28Q1 | 2.18 0.33 down from 2018 | 175 | 96% | $1,670 | ||
20Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 1.27Q1 | 3.65 1.39 up from 2018 | 140 | 17% | $3,730 | ||
21Research and Practice in Thrombosis and HaemostasisOAElsevier BV · United States | 1.24Q2 | 3.00 1.81 up from 2018 | 152 | 100% | $2,250 | ||
22Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 1.23Q2 | 3.21 0.40 down from 2018 | 319 | 39% | — | ||
23PlateletsOAInforma · United Kingdom | 1.22Q2 | 3.23 0.08 up from 2018 | 429 | 14% | $2,970 | ||
24Journal of Blood MedicineOADove Medical Press · New Zealand | 1.15Q2 | 2.46 1.10 down from 2018 | 86 | 100% | $2,320 | ||
25Expert Review of HematologyTaylor & Francis · United Kingdom | 1.13Q2 | 2.98 0.31 up from 2018 | 285 | 21% | — | ||
26Vox SanguinisWiley · United Kingdom | 1.05Q2 | 2.81 0.05 down from 2018 | 291 | 34% | $4,150 | ||
27Current Research in Translational MedicineElsevier BV · France | 1.01Q2 | 2.66 0.04 up from 2018 | 91 | 30% | $3,700 | ||
28Experimental HematologyElsevier BV · United States | 1.01Q2 | 3.06 0.29 up from 2018 | 328 | 97% | $3,250 | ||
29European Journal Of HaematologyWiley · United Kingdom | 0.99Q2 | 2.53 0.15 up from 2018 | 426 | 40% | $4,650 | ||
30Bone Marrow TransplantationSpringer Nature · United Kingdom | 0.98Q2 | 2.58 0.23 down from 2018 | 996 | 38% | $4,990 | ||
31BMC HematologySpringer Science+Business Media · United Kingdom | 0.92Q2 | 2.54 0.62 up from 2018 | 88 | 100% | $2,170 | ||
32TransfusionWiley · United States | 0.90Q2 | 2.65 0.29 down from 2018 | 1,368 | 28% | $4,100 | ||
33Leukemia ResearchElsevier BV · United Kingdom | 0.82Q2 | 2.21 0.01 down from 2018 | 579 | 12% | $3,910 | ||
34Annals of HematologyOASpringer Science+Business Media · Germany | 0.82Q2 | 2.31 0.18 up from 2018 | 974 | 20% | $4,590 | ||
35International Journal of HematologySpringer Science+Business Media · Japan | 0.79Q2 | 2.46 0.21 up from 2018 | 588 | 15% | $4,390 | ||
36Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.77Q2 | 2.00 0.04 down from 2018 | 576 | 7% | $3,890 | ||
37Journal of Clinical ApheresisWiley · United States | 0.77Q2 | 1.48 1.04 down from 2018 | 205 | 25% | $3,920 | ||
38Annals of Laboratory MedicineOASeoul National University · South Korea | 0.70Q2 | 2.08 0.17 up from 2018 | 331 | 100% | — | ||
39Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.69Q2 | 2.04 0.33 up from 2018 | 189 | 100% | $647 | ||
40International Journal of Laboratory HematologyWiley · United Kingdom | 0.69Q2 | 1.80 0.04 down from 2018 | 449 | 25% | $3,880 | ||
41Transfusion MedicineWiley · United Kingdom | 0.68Q3 | 1.88 0.03 down from 2018 | 243 | 19% | $3,700 | ||
42Pediatric Hematology and OncologyTaylor & Francis · United Kingdom | 0.67Q3 | 1.59 0.10 up from 2018 | 157 | 11% | — | ||
43HaemophiliaWiley · United Kingdom | 0.67Q3 | 2.05 0.39 down from 2018 | 708 | 33% | $4,760 | ||
44Transfusion and Apheresis ScienceElsevier BV · United Kingdom | 0.67Q3 | 1.53 0.17 down from 2018 | 464 | 21% | $3,160 | ||
45Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.66Q3 | 1.85 0.14 up from 2018 | 1,298 | 22% | — | ||
46HematologyOAManey Publishing · United Kingdom | 0.62Q3 | 1.72 0.19 up from 2018 | 318 | 100% | $2,557 | ||
47Blood Coagulation & FibrinolysisLippincott Williams & Wilkins · United Kingdom | 0.57Q3 | 1.41 0.05 up from 2018 | 330 | 15% | — | ||
48Cytometry Part B Clinical CytometryWiley · United States | 0.57Q3 | 2.28 0.17 up from 2018 | 228 | 87% | $3,800 | ||
49Acta HaematologicaKarger Publishers · Switzerland | 0.53Q3 | 1.10 0.19 down from 2018 | 235 | 32% | — | ||
50Leukemia Research ReportsOAElsevier BV · Netherlands | 0.53Q3 | 1.25 0.33 down from 2018 | 70 | 100% | $1,180 |
Subfields of Medicine, with Hematology highlighted.
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Hematology80
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2019. Corpus-wide, 83.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
24 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2016–2018, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2019. Publication window: 2016–2018. How these summaries are calculated
- Ranked journals
- 80
- Window papers (baseline)
- 39,004 +9.0% from indicator year 2016
- Median OJR
- 0.68294 -5.1% from indicator year 2016
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2016–2018 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.